The epidermal growth factor receptor ligands at a glance.
about
Mechanisms underlying skin disorders induced by EGFR inhibitorsEGFR Signaling in Liver DiseasesNeuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time windowChallenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategiesEpidermal growth factor, from gene organization to bedsideThe Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entryMolecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading EnzymeUnderstanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyondEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerConstitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance developmentIntegrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasThe novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear.The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFRIdentification of putative drug targets for human sperm-egg interaction defect using protein network approach.Lineage-specific co-evolution of the Egf receptor/ligand signaling system.Serum-dependent selective expression of EhTMKB1-9, a member of Entamoeba histolytica B1 family of transmembrane kinases.Differential transcriptomic responses of Biomphalaria glabrata (Gastropoda, Mollusca) to bacteria and metazoan parasites, Schistosoma mansoni and Echinostoma paraensei (Digenea, Platyhelminthes).Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase.Structure and function of epigen, the last EGFR ligand.Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.The human airway epithelial basal cell transcriptome.From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes.Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cellsEGFR-mutated lung cancer: a paradigm of molecular oncology.Transcriptome analysis of the spalax hypoxia survival response includes suppression of apoptosis and tight control of angiogenesis.The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesisIntracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.Epidermal growth factor receptor down-regulation triggers human myoblast differentiationIn silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common featuresERBB receptor activation is required for profibrotic responses to transforming growth factor beta.Engineered bivalent ligands to bias ErbB receptor-mediated signaling and phenotypes.Emerging picture of the distinct traits and functions of microvesicles and exosomesFunctional aspects of the EGF-induced MAP kinase cascade: a complex self-organizing system approachEGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
P2860
Q26745689-86256CBA-3ADF-4CC7-B83E-C0A7FA59D891Q26771265-6B59D032-07CA-45D5-B6DA-9A7D89E18D8AQ26823783-39D32C27-93CB-4789-A5D7-1AF870EB2A49Q26852366-1A19EF01-5DAD-437C-840C-EA7CDD10EE69Q26865616-8F317A28-2A50-48BD-A00B-E481B0FDD621Q27334989-25222568-DB5D-49A1-A0D9-3A386519B9BFQ27658095-7AF07FA4-CC78-42F6-8CA9-45AEE3F7F7D7Q27691330-2C16B2E4-D765-48DA-8A53-FD167FDE45FDQ28080730-CB9E5367-29A0-4A28-AB51-E958D3BF75FFQ28084216-83675ADD-346A-4F29-8933-22ED8CDEF073Q28386290-0AB79076-0D91-4B36-87AD-4D37F2F588C1Q28475549-BAADC7FA-6978-44F2-8D02-089B5BBA6A06Q28585297-E319B9F3-9889-4320-B814-CDAEC0292E78Q30234893-566A4AB0-8BDB-42A5-AD51-0C5C0B4AF274Q30415389-1F4586D0-A57E-4BE0-9075-1F1CE4D4F789Q30658102-46E40B9E-3C44-44AB-8232-3DA8073E59B2Q33526877-D631CC99-7DAC-45C2-9164-AF4B4F7384C1Q33598601-7024067F-5C4A-4E72-BAF7-A30A4D057C50Q33624555-4D91026A-3A06-40A5-9835-E10C412BC017Q33662459-FD285E1C-DCC0-48B0-8FDE-0F3767479E76Q33680363-AA54B5DF-C020-4B20-A86B-4ED8E2AAF49CQ33815623-C81BC653-3EFD-42BC-9409-C2BA091D6446Q33893381-F36EFE85-0538-45D4-B0AA-C950E6EBA5D2Q33900107-4DE28FC4-CA3C-4DF5-A411-0EC9D2AB9F25Q33926726-300CF1A8-FE40-477C-AD5D-BC12F5EA5CC0Q33998215-E654F737-F36D-45F9-A899-A98E8B89EDC7Q34091593-A455AFF9-ABF5-4C95-9A46-6711BA719B92Q34093520-C01CBF91-7D68-45FB-9AAC-E405977EDEACQ34406334-A17652D3-74B9-4223-BD31-3A57B22D4AA0Q34475725-E1B428FD-C5ED-402D-9AAA-F43F540FF578Q34642326-490DAF84-2977-4FF2-92A2-889F337F5D98Q34751465-99A66C25-8233-4A54-924F-1D4320B6249AQ34959853-C8B0090C-F576-4482-B730-CF6A3FE4F004Q34964456-AF4E60E8-3802-49B6-8558-8D80C312CA08Q34976925-77DF458B-411E-472E-9F21-77F365FD8D5DQ34979224-74C526D6-9D82-473E-8838-884348E47A57Q35145024-5ACAAF57-F173-4D52-ABDD-76A667A69492Q35229477-421EB55D-F529-4B75-A33A-29D3CF5D129CQ35395970-052928F4-3166-4EFE-8EF0-EE9124A1EBC3Q35569862-F9C26D93-AA5C-4C26-9F50-09F14E16F6DC
P2860
The epidermal growth factor receptor ligands at a glance.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The epidermal growth factor receptor ligands at a glance.
@en
The epidermal growth factor receptor ligands at a glance.
@nl
type
label
The epidermal growth factor receptor ligands at a glance.
@en
The epidermal growth factor receptor ligands at a glance.
@nl
prefLabel
The epidermal growth factor receptor ligands at a glance.
@en
The epidermal growth factor receptor ligands at a glance.
@nl
P356
P1476
The epidermal growth factor receptor ligands at a glance.
@en
P304
P356
10.1002/JCP.21635
P577
2009-03-01T00:00:00Z